12 Nov 2020 by admin in UncategorizedComments Kira Pharmaceuticals Launches to Pioneer Novel Therapeutics for Complement-Mediated Diseases
06 Nov 2020 by admin in UncategorizedComments Thermo Fisher Scientific and Innoforce Partner to Establish Biologics and Steriles Drug Manufacturing Facility in China
05 Nov 2020 by admin in UncategorizedComments Syros Pharmaceuticals Reports Third Quarter 2020 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
29 Oct 2020 by admin in UncategorizedComments Centrexion Therapeutics Raises $40.5 Million and Adds Lilly and Exome Asset Management as New Investors
29 Oct 2020 by admin in UncategorizedComments Citrine Medicine Advances Efforts to Create the Very First Rare Disease Ecosystem in China Through Strategic Partnership with Bioprojet to License Exclusive Rights for the Use of Orphan Narcolepsy Therapy Wakix® (pitolisant)
24 Oct 2020 by admin in UncategorizedComments Syros Presents Initial Data from Phase 1Clinical Trial of SY-5609
21 Oct 2020 by admin in UncategorizedComments SAM WHITING, M.D., PH.D., joins TEMPEST as executive vice president and chief medical officer
20 Oct 2020 by admin in UncategorizedComments Design Therapeutics Appoints Industry Veteran, Dr. João Siffert, as Chief Executive Officer
